Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia

NCT06497062 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: sonrotoclax
DRUG: idarubicin/daunorubicin
DRUG: Cytarabine
DRUG: Azacitidine
PROCEDURE: allo-HSCT

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]